Cargando…
Safety and Pharmacokinetics of a Four Monoclonal Antibody Combination against Botulinum C and D Neurotoxins
Botulism is caused by botulinum neurotoxin (BoNT), the most poisonous substance known. BoNTs are also classified as tier 1 biothreat agents due to their high potency and lethality. The existence of seven BoNT serotypes (A to G), which differ by 35% to 68% in amino acid sequences, necessitates the de...
Autores principales: | Snow, Doris M., Riling, Kathryn, Kimbler, Angie, Espinoza, Yero, Wong, David, Pham, Khanh, Martinez, Zachary, Kraus, Carl N., Conrad, Fraser, Garcia-Rodriguez, Consuelo, Cobb, Ronald R., Marks, James D., Tomic, Milan T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6879217/ https://www.ncbi.nlm.nih.gov/pubmed/31591130 http://dx.doi.org/10.1128/AAC.01270-19 |
Ejemplares similares
-
Pharmacokinetics of Human Recombinant Anti-Botulinum Toxin Antibodies in Rats
por: Espinoza, Yero, et al.
Publicado: (2019) -
Neutralizing Concentrations of Anti-Botulinum Toxin Antibodies Positively Correlate with Mouse Neutralization Assay Results in a Guinea Pig Model
por: Tomic, Milan T., et al.
Publicado: (2021) -
Monoclonal Antibodies that Inhibit the Proteolytic Activity of Botulinum Neurotoxin Serotype/B
por: Fan, Yongfeng, et al.
Publicado: (2015) -
A three monoclonal antibody combination potently neutralizes multiple botulinum neurotoxin serotype F subtypes
por: Fan, Yongfeng, et al.
Publicado: (2017) -
Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H
por: Fan, Yongfeng, et al.
Publicado: (2016)